Regulus Therapeutics Inc (RGLS)
2.41
+0.14
(+6.17%)
USD |
NASDAQ |
Apr 26, 16:00
2.41
0.00 (0.00%)
After-Hours: 16:03
Regulus Therapeutics Market Cap: 157.77M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 148.61M |
| April 24, 2024 | 145.33M |
| April 23, 2024 | 147.95M |
| April 22, 2024 | 144.02M |
| April 19, 2024 | 139.44M |
| April 18, 2024 | 145.33M |
| April 17, 2024 | 153.19M |
| April 16, 2024 | 167.59M |
| April 15, 2024 | 181.99M |
| April 12, 2024 | 183.30M |
| April 11, 2024 | 181.99M |
| April 10, 2024 | 171.52M |
| April 09, 2024 | 176.76M |
| April 08, 2024 | 174.79M |
| April 05, 2024 | 166.28M |
| April 04, 2024 | 164.97M |
| April 03, 2024 | 170.86M |
| April 02, 2024 | 178.07M |
| April 01, 2024 | 183.30M |
| March 28, 2024 | 188.54M |
| March 27, 2024 | 188.54M |
| March 26, 2024 | 186.25M |
| March 25, 2024 | 184.61M |
| March 22, 2024 | 175.77M |
| March 21, 2024 | 181.99M |
| Date | Value |
|---|---|
| March 20, 2024 | 163.66M |
| March 19, 2024 | 156.13M |
| March 18, 2024 | 154.50M |
| March 15, 2024 | 138.13M |
| March 14, 2024 | 160.06M |
| March 13, 2024 | 49.46M |
| March 12, 2024 | 48.04M |
| March 11, 2024 | 28.09M |
| March 08, 2024 | 28.11M |
| March 07, 2024 | 28.72M |
| March 06, 2024 | 30.33M |
| March 05, 2024 | 29.93M |
| March 04, 2024 | 30.13M |
| March 01, 2024 | 30.13M |
| February 29, 2024 | 29.73M |
| February 28, 2024 | 30.13M |
| February 27, 2024 | 30.44M |
| February 26, 2024 | 28.72M |
| February 23, 2024 | 29.53M |
| February 22, 2024 | 30.94M |
| February 21, 2024 | 30.54M |
| February 20, 2024 | 31.24M |
| February 16, 2024 | 30.94M |
| February 15, 2024 | 29.93M |
| February 14, 2024 | 29.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.258M
Minimum
Mar 16 2020
188.54M
Maximum
Mar 27 2024
38.72M
Average
27.08M
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals Inc | 2.755B |
| ADMA Biologics Inc | 1.493B |
| FibroGen Inc | 103.22M |
| Protara Therapeutics Inc | 33.56M |
| Amylyx Pharmaceuticals Inc | 118.96M |
Market Cap Related Metrics
| Price to Book Value | 7.448 |
| Price | 2.41 |
| Earnings Yield | -65.56% |